RSS Amplifier

The 'Med AI' Capsule Newsletter by Dr Avneesh Khare · Aug 7, 2025

🩺 OpenAI’s Copilot Cuts Diagnostic Errors, 🏥 GE HealthCare Tops FDA Approvals, 💊 Machine Learning Boosts Personalized Antibiotic Therapy, and More! 🚀

0
Sign in to vote or save

Dr Avneesh Khare · The 'Med AI' Capsule Newsletter by Dr Avneesh Khare

Welcome to The ‘Med AI’ Capsule Newsletter—your go-to source for exploring how AI and emerging technologies are transforming medicine! Whether you're a medical professional 👩‍⚕️, a tech enthusiast 💻, or simply curious 🧠, The 'Med AI' Capsule is for you! Stay ahead of the curve with the latest trends, insights, and updates in the rapidly evolving world of AI and emerging technologies in medicine. 🚀

  • 4 News Updates

  • 3 Research Papers

  • 2 Learning Resources

  • 1 Worth-Attending Event (Physical and Online), and more!

Time to Read: Around 7 to 10 minutes.

Exciting News! You can now enjoy this newsletter issue in a new, accessible format. Click below to listen to the podcast version and dive deeper into the latest insights and stories while on the move!

Listen to the Podcast Version Here

OpenAI and Penda Health partnered for a groundbreaking study using an AI clinical copilot (AI Consult) powered by GPT-4o, deployed in 15 clinics across Nairobi.

  • AI Consult reduced diagnostic errors by 16% and treatment errors by 13% across 39,849 patient visits.

  • History-taking errors fell by 32% and investigation errors by 10%, indicating better clinical documentation and decision-making.

  • When red alerts were triggered, diagnostic errors dropped by 31% and treatment errors by 18%, highlighting a stronger impact in safety-critical cases.

  • With active deployment, the "left in red" rate (unaddressed critical alerts) fell from ~40% to 20%, showing improved clinician engagement.

  • GPT‑4o proved technically capable—real-world integration, not model quality, now limits AI adoption in clinical care.

  • Across 5666 reviewed visits, no harm resulted from AI suggestions; clinicians described AI Consult as a trusted second opinion and learning aid.

    “As AI models advance, the primary challenge ahead is no longer model capability but real-world implementation. Closing the model-implementation gap will require coordinated effort across the health AI ecosystem, including rigorous evaluation and iterative deployment in clinical settings.”

    - Authors

Why It Matters: This study is one of the first large-scale, real-world validations of AI as a clinical copilot. It shows that when thoughtfully implemented, AI can consistently reduce medical errors without compromising clinician autonomy. The findings offer a concrete blueprint for how AI can move from hype to impact—especially in resource-constrained settings—by improving safety, supporting decision-making, and enhancing care quality at scale.

Read More

Cloudphysician uses its AI-centric RADAR platform and video‑copilot agent AINA to convert conventional ICUs into intelligent, monitored environments. Through remote intensivist teams in Bengaluru and proprietary computer‑vision analytics, the company delivers real-time support, operational insights, and critical care oversight to partner hospitals across India.

Check It Out

  • Founded in 2017 by US board‑certified intensivists Dr Dileep Raman and Dr Dhruv Joshi, combining clinical credibility with AI-led care delivery.

  • Active in over 280 hospitals across 23 states, managing more than 2,000 ICU beds, and has supported 130,000+ critical care patients to date.

  • ITheir Smart‑ICU model has achieved up to a 40% reduction in ICU mortality rate, translating to approximately one additional life saved per 10 patients managed.

  • ICU capacity utilization increases of up to 50% enable hospitals to manage complex cases 24/7.

  • Technology stack: The RADAR platform blends computer‑vision and OCR via Google Cloud Vision API, constantly monitors vitals through video feeds, and integrates with Google Meet & Chat to coordinate real‑time care.

  • AI video copilot (AINA): Pre‑trained, disease‑specific video agents track patient motion, detect fall risk, respiratory distress, delirium, low bed rails, and alert teams pro‑actively.

*This edition’s ‘Industry Spotlight’ is editor-picked, not sponsored.

Interested in sponsoring an issue of The 'Med AI' Capsule Newsletter?

Would you like to showcase your innovative health tech brand or product to a community of 25,000+ healthcare technology enthusiasts?

Please feel free to reach out at avneeshkhareonline@gmail.com.

Empirical use of broad-spectrum antibiotics like piperacillin–tazobactam (PIPT) in lower respiratory tract infections (LRTIs) is common but risks overuse and resistance. This study developed a machine learning (ML) model to predict treatment response and guide personalized therapy — with interpretability baked in through SHAP analysis.

  • ML model predicted PIPT treatment response in LRTI patients with 73% accuracy using decision trees.

  • Low serum albumin, high NLR (≥75%), COPD, and heart failure were top predictors of treatment failure.

  • Inadequate PIPT dosage significantly impacted treatment effectiveness.

  • SHAP analysis enabled interpretability, showing how individual factors influence outcomes.

  • Supports personalized antibiotic use and helps reduce inappropriate broad-spectrum prescribing.

“This study demonstrates that the ML model is effective in predicting the outcome of PIPT therapy and helps to personalize medical regimens while adjusting strategies by identifying high-risk individuals, ultimately achieving the dual goals of optimizing patient care and reducing inappropriate antibiotic use.”

- Authors

Why It Matters: By combining machine learning with interpretability, this approach helps clinicians target antibiotics more precisely—improving outcomes while curbing resistance.

Original Paper

Mark your answer and think about it as you read through the remaining newsletter, and find the correct answer at the end!

Check It Out

Get Them Here

Your feedback is crucial to me, as it helps me understand your interests and improve my offerings. I would appreciate it if you could take a few minutes to share your thoughts about what you've enjoyed and what you think I could do better.

PLEASE SHARE FEEDBACK HERE

Register Here

Register Here

“The greatest opportunity offered by AI is not reducing errors or workloads, or even curing cancer: it is the opportunity to restore the precious and time-honored connection and trust—the human touch—between patients and doctors.”
— Eric Topol, Deep Medicine

Stay tuned for the upcoming issues of my newsletter to explore the latest breakthroughs and dive deep into the transformative power of artificial intelligence and emerging technologies, shaping a healthier future. 🚀

www.avneeshkhare.com

Disclaimer: The content in this newsletter was partly curated and summarized using AI LLMs, which can make mistakes. Please check all important information. For any issues or inaccuracies, please reach out at avneeshkhareonline@gmail.com.

✅ Correct Answer:
B) Reduced diagnostic errors
💡 Explanation:
OpenAI’s AI clinical copilot, used in Penda Health’s study, led to a 16% reduction in diagnostic errors and also decreased treatment, history-taking, and investigation errors across nearly 40,000 patient visits. This demonstrates that the AI’s main advantage was improving diagnostic accuracy, making it a valuable, trusted second opinion for clinicians while enhancing care safety and quality.

Read the original on avneeshkhare.substack.com

Comments

Nothing yet. Say the first thing.

    Sign in to join the conversation.